Raman VS - Search Results

1

CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen.

Elgueta R, Marks E, Nowak E, Menezes S, Benson M, Raman VS, Ortiz C, O'Connell S, Hess H, Lord GM, Noelle R. Elgueta R, et al. Among authors: raman vs. J Immunol. 2015 Jan 15;194(2):505-13. doi: 10.4049/jimmunol.1401553. Epub 2014 Dec 12. J Immunol. 2015. PMID: 25505290 Free PMC article.

2

Strategies for selective priming of memory B cells.

Raman VS, Lind EF, Benson MJ, Noelle RJ. Raman VS, et al. Immunol Lett. 2007 Apr 15;109(2):93-100. doi: 10.1016/j.imlet.2007.01.010. Epub 2007 Feb 27. Immunol Lett. 2007. PMID: 17374402 Free PMC article.

3

BCMA is essential for the survival of long-lived bone marrow plasma cells.

O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ. O'Connor BP, et al. Among authors: raman vs. J Exp Med. 2004 Jan 5;199(1):91-8. doi: 10.1084/jem.20031330. J Exp Med. 2004. PMID: 14707116 Free PMC article.

4

The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.

Lu LF, Ahonen CL, Lind EF, Raman VS, Cook WJ, Lin LL, Noelle RJ. Lu LF, et al. Among authors: raman vs. Blood. 2007 Jul 1;110(1):193-200. doi: 10.1182/blood-2006-07-038414. Epub 2007 Mar 14. Blood. 2007. PMID: 17360936 Free PMC article.

5

Ligation of CD27 on B cells in vivo during primary immunization enhances commitment to memory B cell responses.

Raman VS, Akondy RS, Rath S, Bal V, George A. Raman VS, et al. J Immunol. 2003 Dec 1;171(11):5876-81. doi: 10.4049/jimmunol.171.11.5876. J Immunol. 2003. PMID: 14634097

6

Ligation of CD27 on murine B cells responding to T-dependent and T-independent stimuli inhibits the generation of plasma cells.

Raman VS, Bal V, Rath S, George A. Raman VS, et al. J Immunol. 2000 Dec 15;165(12):6809-15. doi: 10.4049/jimmunol.165.12.6809. J Immunol. 2000. PMID: 11120803

7

Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.

Raman VS, Bhatia A, Picone A, Whittle J, Bailor HR, O'Donnell J, Pattabhi S, Guderian JA, Mohamath R, Duthie MS, Reed SG. Raman VS, et al. J Immunol. 2010 Aug 1;185(3):1701-10. doi: 10.4049/jimmunol.1000238. Epub 2010 Jul 2. J Immunol. 2010. PMID: 20601594 Free PMC article.

8

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate.

Lousada-Dietrich S, Jogdand PS, Jepsen S, Pinto VV, Ditlev SB, Christiansen M, Larsen SO, Fox CB, Raman VS, Howard RF, Vedvick TS, Ireton G, Carter D, Reed SG, Theisen M. Lousada-Dietrich S, et al. Among authors: raman vs. Vaccine. 2011 Apr 12;29(17):3284-92. doi: 10.1016/j.vaccine.2011.02.022. Epub 2011 Feb 22. Vaccine. 2011. PMID: 21349366

9

Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Raman VS, O'Donnell J, Bailor HR, Goto W, Lahiri R, Gillis TP, Reed SG, Duthie MS. Raman VS, et al. Infect Immun. 2009 Dec;77(12):5623-30. doi: 10.1128/IAI.00508-09. Epub 2009 Sep 28. Infect Immun. 2009. PMID: 19786561 Free PMC article.

10

KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.

Goto Y, Bhatia A, Raman VS, Liang H, Mohamath R, Picone AF, Vidal SE, Vedvick TS, Howard RF, Reed SG. Goto Y, et al. Among authors: raman vs. Clin Vaccine Immunol. 2011 Jul;18(7):1118-24. doi: 10.1128/CVI.05024-11. Epub 2011 Jun 1. Clin Vaccine Immunol. 2011. PMID: 21632891 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page